About IBA-Lifescience
IBA-Lifescience is a company based in Gottingen (Germany) founded in 1996 was acquired by ARCHIMED in January 2025. IBA-Lifescience offers products and services including MagStrep Strep-Tactin XT beads, Strep-Tactin XT 4Flow resin, and Twin-Strep-tag Capture Kit. IBA-Lifescience operates in a competitive market with competitors including Abcam, ArcherDX, Stem Cell Technologies, OriGene and Sangon Biotech, among others.
Products & Services of IBA-Lifescience
IBA-Lifescience offers a comprehensive portfolio of products and services, including MagStrep Strep-Tactin XT beads, Strep-Tactin XT 4Flow resin, and Twin-Strep-tag Capture Kit.
Magnetic beads for purifying Strep-tag fusion proteins in research
Resin for high-capacity protein purification applications
Kit for reversible capture in biomolecular interaction studies
Apps and channels of IBA-Lifescience
its YouTube channel IBA Lifesciences has 574 subscribers and 29 videos.
Videos from IBA-Lifescience
The most watched videos on IBA-Lifescience's YouTube channel, IBA Lifesciences (574 subscribers). Click a video to play it here.
More on IBA Lifesciences.
Investors in IBA-Lifescience
IBA-Lifescience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include ARCHIMED.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare industries are funded and supported globally by ARCHIMED. | – | archimed.group | Lyon, France |
Investor details for IBA-Lifescience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of IBA-Lifescience
14 people are tracked at IBA-Lifescience (7 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Christos Gouloudis | Director Of Protein Production | Leadership |
Dr. Franziska Hartung | Manufacturing Director | Leadership |
Simone Gerlach | HR Director | Leadership |
Dr. Joachim Bertram | Managing Director | Leadership |
Mike Rothe | CEO | Leadership |
Anna Färger | Director Marketing | Leadership |
Fabian Mohr | Chief Scientific Officer | Leadership |
Anna Alekseeva | Marketing Manager | Team |
Dr. Isabel Schuchardt | Product Manager | Team |
Wilhelm Gerdes | BDM | Team |
Kreshnik Zyka | Information Technology Administrator | Team |
Philipp Henning | Team Lead | Team |
Jingyue Yuan | Business Manager Asia | Team |
Lisa Breithaupt | Manager Production And Quality Control | Team |
Complete people profiles for IBA-Lifescience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of IBA-Lifescience
2 dated milestones of IBA-Lifescience across 29 years, from founding to its latest funding, stage changes and deals.
- Founded IBA-Lifescience is founded.
- Exit Acquired by ARCHIMED.
Competitors of IBA-Lifescience
IBA-Lifescience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, ArcherDX, Stem Cell Technologies, OriGene and Sangon Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abcam.com | 1998 | Cambridge, United Kingdom | $78.8M | 405 | Biological reagents and antibodies are developed for life science research. | |
| archerdx.com | 2013 | Boulder, United States | $152.6M | 429 | Molecular cancer diagnostic products are developed using patented AMP technology. | |
| stemcell.com | 1993 | Vancouver, Canada | $11.92M | 129 | Developer of cell culture media and ancillary reagents for life science research | |
| origene.com | 1996 | Rockville, United States | $69.55M | 141 | Proteins, antibodies, and molecular tools are manufactured for research applications. | |
| sangon.com | 2003 | Shanghai, China | $300M | – | Research services, reagents, and kits for biotech applications are provided. | |
| meridianbioscience.com | 1976 | Ohio, United States | – | – | Molecular diagnostic device and kits | |
| teknova.com | 1996 | Hollister, United States | – | 290 | Molecular biology reagents and kits are supplied for research applications. | |
| caymanchem.com | 1980 | Ann Arbor, United States | – | 309 | Bioreagents and assay kits are developed, with preclinical services provided. | |
| abclonal.com | 2006 | Woburn, United States | $281.25M | – | Developer of protein and peptide reagents and kits for cell and molecular biology research |
Detailed competitors of IBA-Lifescience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of IBA-Lifescience
The website of IBA-Lifescience (iba-lifesciences.com) receives about 15.2K visits a month.
- Monthly visits15.2K
▼ 6.2% vs previous month
Websites whose visitors overlap most with IBA-Lifescience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| neuromics.com | 100% | 25.3K | #1,118,534 | View details | |
stratech.co.uk | stratech.co.uk | 94% | – | #1,782,305 | – |
| solulink.com | 94% | – | – | View details | |
| cube-biotech.com | 83% | 37.6K | #839,936 | View details | |
| jenabioscience.com | 80% | 47.7K | #685,479 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for IBA-Lifescience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Iba-Lifescience
Complete news archive for IBA-Lifescience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to IBA-Lifescience
10 companies that operate in the same segment as IBA-Lifescience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about IBA-Lifescience
IBA-Lifescience was founded in 1996.
IBA-Lifescience is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.
IBA-Lifescience was founded in 1996 in Gottingen, Germany, within the biotechnology sector. Tools and reagents for cell biology research are provided, including Fab-TACS technology developed for cell selection from whole blood via Strep-Tactin TACS Agarose columns. Strep-tag protein purification and detection assays are also offered to support laboratory operations in this field.
IBA-Lifescience's top competitors include Abcam, Meridian Bioscience and ArcherDX.
IBA-Lifescience offers MagStrep Strep-Tactin XT beads, Strep-Tactin XT 4Flow resin, and Twin-Strep-tag Capture Kit.
IBA-Lifescience has 1 investor. Key investors include ARCHIMED.
IBA-Lifescience operates through Iba Lifesciences Gmbh.
Yes. IBA-Lifescience was acquired by ARCHIMED in January 2025.